ASMB
Assembly Biosciences Inc

4,223
Mkt Cap
$597.73M
Volume
30.00
52W High
$39.71
52W Low
$7.75
PE Ratio
-7.87
ASMB Fundamentals
Price
$37.79
Prev Close
$37.19
Open
$37.49
50D MA
$30.13
Beta
1.02
Avg. Volume
135,617.39
EPS (Annual)
-$6.69
P/B
3.27
Rev/Employee
$390,684.93
Loading...
Loading...
News
all
press releases
Assembly Biosciences, Inc. (NASDAQ:ASMB) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB - Get Free Report) have been assigned an average rating of "Moderate Buy" from the seven research firms that are presently covering the stock...
MarketBeat·17d ago
News Placeholder
More News
News Placeholder
Assembly Biosciences (NASDAQ:ASMB) Releases Quarterly Earnings Results, Misses Estimates By $0.22 EPS
Assembly Biosciences (NASDAQ:ASMB - Get Free Report) issued its quarterly earnings data on Monday. The biopharmaceutical company reported ($0.72) earnings per share (EPS) for the quarter, missing the...
MarketBeat·20d ago
News Placeholder
Supernus Pharmaceuticals (SUPN) Surpasses Q3 Earnings and Revenue Estimates
Supernus (SUPN) delivered earnings and revenue surprises of +23.17% and +5.52%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·27d ago
News Placeholder
Assembly Biosciences (ASMB) Surges 9.8%: Is This an Indication of Further Gains?
Assembly Biosciences (ASMB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·2mo ago
News Placeholder
Assembly Biosciences' Investigational Herpes Treatment Shows Antiviral Efficacy, Safety In Healthy Participants
Assembly Biosciences reported interim results from its Phase 1a study of ABI-5366, a long-acting HSV inhibitor for recurrent genital herpes. The drug showed a favorable safety profile and achieved...
Benzinga·1y ago
News Placeholder
Futures Fall As Fed Frenzy Fades And Traders Brace For $4.5 Trillion Quad Witch OpEx
Futures Fall As Fed Frenzy Fades And Traders Brace For $4.5 Trillion Quad Witch OpEx After yesterday's delayed (and technically-driven) post-rate cut meltup, futures are set to close the...
Zero Hedge·1y ago
News Placeholder
Assembly Biosciences (NASDAQ:ASMB) Lifted to Hold at StockNews.com
StockNews.com upgraded shares of Assembly Biosciences (NASDAQ:ASMB - Free Report) from a sell rating to a hold rating in a research report released on Friday. Separately, HC Wainwright reiterated a...
Ticker Report·2y ago
News Placeholder
Assembly Biosciences (NASDAQ:ASMB) Rating Increased to Hold at StockNews.com
Assembly Biosciences (NASDAQ:ASMB - Get Free Report) was upgraded by StockNews.com from a "sell" rating to a "hold" rating in a research note issued to investors on Friday. Separately, HC Wainwright...
Zolmax·2y ago
News Placeholder
Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Natera (NTRA) and Disc Medicine (IRON)
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Assembly Biosciences (ASMB Research Report), Nater...
TipRanks Financial Blog·2y ago
News Placeholder
Assembly Biosciences, Inc. (NASDAQ:ASMB) Director John G. Mchutchison Sells 1,206 Shares
Assembly Biosciences, Inc. (NASDAQ:ASMB - Get Free Report) Director John G. Mchutchison sold 1,206 shares of the stock in a transaction on Monday, April 1st. The stock was sold at an average price of...
Ticker Report·2y ago

Latest ASMB News

View

Advertisement|Remove ads.

Advertisement|Remove ads.